Report Detail

Other Global Iduronate 2 Sulfatase Market Size, Status and Forecast 2019-2025

  • RnM2749064
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Iduronate 2 Sulfatase Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Alpha L Iduronate Sulfate Sulfatase
      • 1.4.3 Idursulfase
      • 1.4.4 IDS
      • 1.4.5 EC 3.1.6.13
    • 1.5 Market by Application
      • 1.5.1 Global Iduronate 2 Sulfatase Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Centers
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Iduronate 2 Sulfatase Market Size
    • 2.2 Iduronate 2 Sulfatase Growth Trends by Regions
      • 2.2.1 Iduronate 2 Sulfatase Market Size by Regions (2014-2025)
      • 2.2.2 Iduronate 2 Sulfatase Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Iduronate 2 Sulfatase Market Size by Manufacturers
      • 3.1.1 Global Iduronate 2 Sulfatase Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Iduronate 2 Sulfatase Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Iduronate 2 Sulfatase Market Concentration Ratio (CR5 and HHI)
    • 3.2 Iduronate 2 Sulfatase Key Players Head office and Area Served
    • 3.3 Key Players Iduronate 2 Sulfatase Product/Solution/Service
    • 3.4 Date of Enter into Iduronate 2 Sulfatase Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Iduronate 2 Sulfatase Market Size by Type (2014-2019)
    • 4.2 Global Iduronate 2 Sulfatase Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Iduronate 2 Sulfatase Market Size (2014-2019)
    • 5.2 Iduronate 2 Sulfatase Key Players in United States
    • 5.3 United States Iduronate 2 Sulfatase Market Size by Type
    • 5.4 United States Iduronate 2 Sulfatase Market Size by Application

    6 Europe

    • 6.1 Europe Iduronate 2 Sulfatase Market Size (2014-2019)
    • 6.2 Iduronate 2 Sulfatase Key Players in Europe
    • 6.3 Europe Iduronate 2 Sulfatase Market Size by Type
    • 6.4 Europe Iduronate 2 Sulfatase Market Size by Application

    7 China

    • 7.1 China Iduronate 2 Sulfatase Market Size (2014-2019)
    • 7.2 Iduronate 2 Sulfatase Key Players in China
    • 7.3 China Iduronate 2 Sulfatase Market Size by Type
    • 7.4 China Iduronate 2 Sulfatase Market Size by Application

    8 Japan

    • 8.1 Japan Iduronate 2 Sulfatase Market Size (2014-2019)
    • 8.2 Iduronate 2 Sulfatase Key Players in Japan
    • 8.3 Japan Iduronate 2 Sulfatase Market Size by Type
    • 8.4 Japan Iduronate 2 Sulfatase Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Iduronate 2 Sulfatase Market Size (2014-2019)
    • 9.2 Iduronate 2 Sulfatase Key Players in Southeast Asia
    • 9.3 Southeast Asia Iduronate 2 Sulfatase Market Size by Type
    • 9.4 Southeast Asia Iduronate 2 Sulfatase Market Size by Application

    10 India

    • 10.1 India Iduronate 2 Sulfatase Market Size (2014-2019)
    • 10.2 Iduronate 2 Sulfatase Key Players in India
    • 10.3 India Iduronate 2 Sulfatase Market Size by Type
    • 10.4 India Iduronate 2 Sulfatase Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Iduronate 2 Sulfatase Market Size (2014-2019)
    • 11.2 Iduronate 2 Sulfatase Key Players in Central & South America
    • 11.3 Central & South America Iduronate 2 Sulfatase Market Size by Type
    • 11.4 Central & South America Iduronate 2 Sulfatase Market Size by Application

    12 International Players Profiles

    • 12.1 AngioChem
      • 12.1.1 AngioChem Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Iduronate 2 Sulfatase Introduction
      • 12.1.4 AngioChem Revenue in Iduronate 2 Sulfatase Business (2014-2019)
      • 12.1.5 AngioChem Recent Development
    • 12.2 ArmaGen
      • 12.2.1 ArmaGen Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Iduronate 2 Sulfatase Introduction
      • 12.2.4 ArmaGen Revenue in Iduronate 2 Sulfatase Business (2014-2019)
      • 12.2.5 ArmaGen Recent Development
    • 12.3 Bioasis Technologies
      • 12.3.1 Bioasis Technologies Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Iduronate 2 Sulfatase Introduction
      • 12.3.4 Bioasis Technologies Revenue in Iduronate 2 Sulfatase Business (2014-2019)
      • 12.3.5 Bioasis Technologies Recent Development
    • 12.4 Green Cross
      • 12.4.1 Green Cross Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Iduronate 2 Sulfatase Introduction
      • 12.4.4 Green Cross Revenue in Iduronate 2 Sulfatase Business (2014-2019)
      • 12.4.5 Green Cross Recent Development
    • 12.5 JCR Pharmaceuticals
      • 12.5.1 JCR Pharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Iduronate 2 Sulfatase Introduction
      • 12.5.4 JCR Pharmaceuticals Revenue in Iduronate 2 Sulfatase Business (2014-2019)
      • 12.5.5 JCR Pharmaceuticals Recent Development
    • 12.6 Esteve
      • 12.6.1 Esteve Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Iduronate 2 Sulfatase Introduction
      • 12.6.4 Esteve Revenue in Iduronate 2 Sulfatase Business (2014-2019)
      • 12.6.5 Esteve Recent Development
    • 12.7 RegenxBio
      • 12.7.1 RegenxBio Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Iduronate 2 Sulfatase Introduction
      • 12.7.4 RegenxBio Revenue in Iduronate 2 Sulfatase Business (2014-2019)
      • 12.7.5 RegenxBio Recent Development
    • 12.8 Sangamo BioSciences
      • 12.8.1 Sangamo BioSciences Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Iduronate 2 Sulfatase Introduction
      • 12.8.4 Sangamo BioSciences Revenue in Iduronate 2 Sulfatase Business (2014-2019)
      • 12.8.5 Sangamo BioSciences Recent Development
    • 12.9 Shire
      • 12.9.1 Shire Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Iduronate 2 Sulfatase Introduction
      • 12.9.4 Shire Revenue in Iduronate 2 Sulfatase Business (2014-2019)
      • 12.9.5 Shire Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes.
      Iduronate 2-sulfatase (IDS) is a sulfatase enzyme associated with Hunter syndrome. Iduronate 2-sulfatase is required for the lysosomal degradation of heparan sulfate and dermatan sulfate. Mutations in this X-chromosome gene that result in enzymatic deficiency lead to Hunter syndrome.
      In 2018, the global Iduronate 2 Sulfatase market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Iduronate 2 Sulfatase status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Iduronate 2 Sulfatase development in United States, Europe and China.

      The key players covered in this study
      AngioChem
      ArmaGen
      Bioasis Technologies
      Green Cross
      JCR Pharmaceuticals
      Esteve
      RegenxBio
      Sangamo BioSciences
      Shire

      Market segment by Type, the product can be split into
      Alpha L Iduronate Sulfate Sulfatase
      Idursulfase
      IDS
      EC 3.1.6.13

      Market segment by Application, split into
      Hospitals
      Ambulatory Surgical Centers
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Iduronate 2 Sulfatase status, future forecast, growth opportunity, key market and key players.
      To present the Iduronate 2 Sulfatase development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Iduronate 2 Sulfatase are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Iduronate 2 Sulfatase . Industry analysis & Market Report on Iduronate 2 Sulfatase is a syndicated market report, published as Global Iduronate 2 Sulfatase Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Iduronate 2 Sulfatase market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,081.12
      4,621.69
      6,162.25
      3,537.80
      5,306.70
      7,075.60
      423,126.60
      634,689.90
      846,253.20
      278,422.17
      417,633.26
      556,844.34
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report